Key result
MX2 forms cytoplasmic biomolecular condensates with FG-rich proteins that act as nuclear pore decoys, trapping HIV-1 and HSV-1 capsids to prevent nuclear entry of viral genomes.
Why the study?
Human myxovirus resistance 2 restricts HIV-1 and herpesviruses post-entry via capsid interaction, but the involvement of other host cell factors remains poorly understood.
MX2 restricts HIV-1 and HSV-1 by forming cytoplasmic condensates that act as nuclear pore decoys, trapping viral capsids and preventing nuclear entry.
Identifies MX2 cofactors in nuclear pores and RNP granules; leaves open their roles in post-entry viral restriction.
Human myxovirus resistance 2 (MX2) can restrict HIV-1 and herpesviruses at a post-entry step through a process requiring an interaction between MX2 and the viral capsids. The involvement of other host cell factors, however, remains poorly understood. Here, we mapped the proximity interactome of MX2, revealing strong enrichment of phenylalanine-glycine (FG)-rich proteins related to the nuclear pore complex as well as proteins that are part of cytoplasmic ribonucleoprotein granules. MX2 interacted with these proteins to form multiprotein cytoplasmic biomolecular condensates that were essential for its anti-HIV-1 and anti-herpes simplex virus 1 (HSV-1) activity. MX2 condensate formation required the disordered N-terminal region and MX2 dimerization. Incoming HIV-1 and HSV-1 capsids associated with MX2 at these dynamic cytoplasmic biomolecular condensates, preventing nuclear entry of their viral genomes. Thus, MX2 forms cytoplasmic condensates that likely act as nuclear pore decoys, trapping capsids and inducing premature viral genome release to interfere with nuclear targeting of HIV-1 and HSV-1.
No takes yet. Share an insight, caveat, or question.
Moschonas et al. (2024) studied HIV-1 and herpes simplex virus 1 (HSV-1) infection. MX2 was evaluated on MX2 proximity interactome and mechanism of viral restriction. MX2 forms cytoplasmic biomolecular condensates with FG-rich proteins that act as nuclear pore decoys, trapping HIV-1 and HSV-1 capsids to prevent nuclear entry of viral genomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: